@melisandrePro @wacki17 You’d have to also limit HIV replication while you did it. The early Chinese trials who wer…
You'd have to also limit HIV replication while you did it. The early Chinese trials who were treated with Kaletra. If any of them were HIV+, they'd be worth retesting.
— Adam Gaertner (@veryvirology) May 29, 2020